24
T. K. Barik et al.
95. Elsaesser A, Howard CV (2012) Toxicology of nanoparticles. Adv Drug Deliv Rev
96. Pridgen EM, Alexis F, Farokhzad OC (2015) Polymeric nanoparticle drug delivery technologies for oral delivery applications. Expert Opin Drug Deliv
97. Kafshgari M, Harding F, Voelcker N (2015) Insights into cellular uptake of nanoparticles.
Curr Drug Deliv. https://doi.org/10.2174/1567201811666140821110631
98. De Jong WH, Borm PJA (2008) Drug delivery and nanoparticles: applications and hazards.
Int J Nanomedicine 3:133–149
99. Papp T, Schiffmann D, Weiss D, Castranova V, Vallyathan V, Rahman Q (2008) Human health
implications of nanomaterial exposure. Nanotoxicology 2:9–27. https://doi.org/10.1080/174
35390701847935
100. Likus W, Bajor G, Siemianowicz K (2013) Nanosilver-does it have only one face?
101. Oberdörster G, Oberdörster E, Oberdörster J (2005) Nanotoxicology: an emerging discipline
evolving from studies of ultrafine particles. Environ Health Perspect 113:823–839
102. Love SA, Maurer-Jones MA, Thompson JW, Lin Y-S, Haynes CL (2012) Assessing
nanoparticle toxicity. Annu Rev Anal Chem. https://doi.org/10.1146/annurev-anchem-062
011-143134
103. Ahamed M, AlSalhi MS, Siddiqui MKJ (2010) Silver nanoparticle applications and human
health. Clin. Chim, Acta
104. Manke A, Wang L, Rojanasakul Y (2013) Mechanisms of nanoparticle-induced oxidative
stress and toxicity. Biomed Res, Int
105. Beer C, Foldbjerg R, Hayashi Y, Sutherland DS, Autrup H (2012) Toxicity of silver
nanoparticles-Nanoparticle or silver ion? Toxicol Lett. https://doi.org/10.1016/j.toxlet.2011.
11.002
106. Liao MY, Liu HG (2012) Gene expression profiling of nephrotoxicity from copper nanoparticles in rats after repeated oral administration. Environ Toxicol Pharmacol 34:67–80. https://
doi.org/10.1016/j.etap.2011.05.014
107. La Francesca S (2012) Nanotechnology and stem cell therapy for cardiovascular diseases:
potential applications. Methodist Debakey Cardiovasc J 8:28–35
108. Singh R, Lillard JW (2009) Nanoparticle-based targeted drug delivery. Exp. Mol, Pathol
109. Wang AZ, Langer R, Farokhzad OC (2012) Nanoparticle delivery of cancer drugs. Annu Rev
Med. https://doi.org/10.1146/annurev-med-040210-162544
110. Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W, Wurm EMT, Yoong C, Robertson
TA, Soyer HP, Roberts MS (2011) Nanoparticles and microparticles for skin drug delivery.
Adv Drug Deliv, Rev
111. Xie J, Lee S, Chen X (2010) Nanoparticle-based theranostic agents. Adv Drug Deliv, Rev
112. Brannon-Peppas L, Blanchette JO (2004) Nanoparticle and targeted systems for cancer
therapy. Adv Drug Deliv Rev 56:1649–1659
113. Gerloff K, Albrecht C, Boots AW, Frster I, Schins RPF (2009) Cytotoxicity and oxidative
DNA damage by nanoparticles in human intestinal Caco-2 cells. Nanotoxicology 3:355–364.
https://doi.org/10.3109/17435390903276933
114. Relating cytotoxicity, zinc ions, and reactive oxygen in ZnO nanoparticle-exposed human
immune cells. | Semantic Scholar. https://www.semanticscholar.org/paper/Relating-cytoto
xicity%2C-zinc-ions%2C-and-reactive-in-Shen-James/95df5b01a4a932d2c233884e7a4c9e
8dcd942169. Accessed 9 June 2020
115. Yan G, Huang Y, Bu Q, Lv L, Deng P, Zhou J, Wang Y, Yang Y, Liu Q, Cen X, Zhao Y (2012)
Zinc oxide nanoparticles cause nephrotoxicity and kidney metabolism alterations in rats. J
Environ Sci Heal Part A 47:577–588. https://doi.org/10.1080/10934529.2012.650576
116. Sahu SC, Zheng J, Graham L, Chen L, Ihrie J, Yourick JJ, Sprando RL (2014) Comparative
cytotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells in culture. J Appl
Toxicol 34:1155–1166. https://doi.org/10.1002/jat.2994
117. Semmler M, Seitz J, Erbe F, Mayer P, Heyder J, Oberdörster G, Kreyling WG (2004) Longterm clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung,
including transient translocation into secondary organs. In: Inhalation Toxicology, pp 453–459
T. K. Barik et al.
95. Elsaesser A, Howard CV (2012) Toxicology of nanoparticles. Adv Drug Deliv Rev
96. Pridgen EM, Alexis F, Farokhzad OC (2015) Polymeric nanoparticle drug delivery technologies for oral delivery applications. Expert Opin Drug Deliv
97. Kafshgari M, Harding F, Voelcker N (2015) Insights into cellular uptake of nanoparticles.
Curr Drug Deliv. https://doi.org/10.2174/1567201811666140821110631
98. De Jong WH, Borm PJA (2008) Drug delivery and nanoparticles: applications and hazards.
Int J Nanomedicine 3:133–149
99. Papp T, Schiffmann D, Weiss D, Castranova V, Vallyathan V, Rahman Q (2008) Human health
implications of nanomaterial exposure. Nanotoxicology 2:9–27. https://doi.org/10.1080/174
35390701847935
100. Likus W, Bajor G, Siemianowicz K (2013) Nanosilver-does it have only one face?
101. Oberdörster G, Oberdörster E, Oberdörster J (2005) Nanotoxicology: an emerging discipline
evolving from studies of ultrafine particles. Environ Health Perspect 113:823–839
102. Love SA, Maurer-Jones MA, Thompson JW, Lin Y-S, Haynes CL (2012) Assessing
nanoparticle toxicity. Annu Rev Anal Chem. https://doi.org/10.1146/annurev-anchem-062
011-143134
103. Ahamed M, AlSalhi MS, Siddiqui MKJ (2010) Silver nanoparticle applications and human
health. Clin. Chim, Acta
104. Manke A, Wang L, Rojanasakul Y (2013) Mechanisms of nanoparticle-induced oxidative
stress and toxicity. Biomed Res, Int
105. Beer C, Foldbjerg R, Hayashi Y, Sutherland DS, Autrup H (2012) Toxicity of silver
nanoparticles-Nanoparticle or silver ion? Toxicol Lett. https://doi.org/10.1016/j.toxlet.2011.
11.002
106. Liao MY, Liu HG (2012) Gene expression profiling of nephrotoxicity from copper nanoparticles in rats after repeated oral administration. Environ Toxicol Pharmacol 34:67–80. https://
doi.org/10.1016/j.etap.2011.05.014
107. La Francesca S (2012) Nanotechnology and stem cell therapy for cardiovascular diseases:
potential applications. Methodist Debakey Cardiovasc J 8:28–35
108. Singh R, Lillard JW (2009) Nanoparticle-based targeted drug delivery. Exp. Mol, Pathol
109. Wang AZ, Langer R, Farokhzad OC (2012) Nanoparticle delivery of cancer drugs. Annu Rev
Med. https://doi.org/10.1146/annurev-med-040210-162544
110. Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W, Wurm EMT, Yoong C, Robertson
TA, Soyer HP, Roberts MS (2011) Nanoparticles and microparticles for skin drug delivery.
Adv Drug Deliv, Rev
111. Xie J, Lee S, Chen X (2010) Nanoparticle-based theranostic agents. Adv Drug Deliv, Rev
112. Brannon-Peppas L, Blanchette JO (2004) Nanoparticle and targeted systems for cancer
therapy. Adv Drug Deliv Rev 56:1649–1659
113. Gerloff K, Albrecht C, Boots AW, Frster I, Schins RPF (2009) Cytotoxicity and oxidative
DNA damage by nanoparticles in human intestinal Caco-2 cells. Nanotoxicology 3:355–364.
https://doi.org/10.3109/17435390903276933
114. Relating cytotoxicity, zinc ions, and reactive oxygen in ZnO nanoparticle-exposed human
immune cells. | Semantic Scholar. https://www.semanticscholar.org/paper/Relating-cytoto
xicity%2C-zinc-ions%2C-and-reactive-in-Shen-James/95df5b01a4a932d2c233884e7a4c9e
8dcd942169. Accessed 9 June 2020
115. Yan G, Huang Y, Bu Q, Lv L, Deng P, Zhou J, Wang Y, Yang Y, Liu Q, Cen X, Zhao Y (2012)
Zinc oxide nanoparticles cause nephrotoxicity and kidney metabolism alterations in rats. J
Environ Sci Heal Part A 47:577–588. https://doi.org/10.1080/10934529.2012.650576
116. Sahu SC, Zheng J, Graham L, Chen L, Ihrie J, Yourick JJ, Sprando RL (2014) Comparative
cytotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells in culture. J Appl
Toxicol 34:1155–1166. https://doi.org/10.1002/jat.2994
117. Semmler M, Seitz J, Erbe F, Mayer P, Heyder J, Oberdörster G, Kreyling WG (2004) Longterm clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung,
including transient translocation into secondary organs. In: Inhalation Toxicology, pp 453–459